X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (91) 91
index medicus (76) 76
male (69) 69
female (58) 58
middle aged (55) 55
aged (46) 46
adult (42) 42
infectious diseases (38) 38
mortality (26) 26
internal medicine (25) 25
microbiology (25) 25
treatment outcome (25) 25
infective endocarditis (24) 24
medicine, general & internal (24) 24
risk factors (24) 24
endocarditis (22) 22
management (21) 21
surgery (21) 21
diagnosis (20) 20
health aspects (20) 20
pharmacology & pharmacy (20) 20
aged, 80 and over (19) 19
anti-bacterial agents - therapeutic use (18) 18
prospective studies (18) 18
care and treatment (17) 17
infections (15) 15
medicine & public health (15) 15
therapy (15) 15
colistin (13) 13
heart (13) 13
hepatitis c, chronic - drug therapy (13) 13
analysis (12) 12
gram-negative bacteria (12) 12
immunology (12) 12
infection (12) 12
prevalence (12) 12
antibiotics (11) 11
cardiac & cardiovascular systems (11) 11
risk (11) 11
transplantation (11) 11
young adult (11) 11
adolescent (10) 10
cohort studies (10) 10
endocarditis - mortality (10) 10
epidemiology (10) 10
gastroenterology & hepatology (10) 10
hepatitis c (10) 10
infectious disease (10) 10
life sciences (10) 10
prognosis (10) 10
risk-factors (10) 10
antiviral agents - therapeutic use (9) 9
interferon-alpha - therapeutic use (9) 9
recombinant proteins (9) 9
retrospective studies (9) 9
virology (9) 9
acinetobacter baumannii - drug effects (8) 8
antimicrobial therapy (8) 8
combination therapy (8) 8
endocarditis, bacterial - epidemiology (8) 8
hospital mortality (8) 8
hospitalization (8) 8
impact (8) 8
infectious medicine (8) 8
infektionsmedicin (8) 8
italy (8) 8
italy - epidemiology (8) 8
multicenter (8) 8
patients (8) 8
abridged index medicus (7) 7
acinetobacter baumannii (7) 7
age factors (7) 7
critically-ill patients (7) 7
disease (7) 7
drug resistance (7) 7
drug resistance, multiple, bacterial (7) 7
drug therapy, combination (7) 7
follow-up studies (7) 7
hepatitis (7) 7
human health and pathology (7) 7
medical research (7) 7
medicine, experimental (7) 7
outcomes (7) 7
patient outcomes (7) 7
research (7) 7
usage (7) 7
valve endocarditis (7) 7
acinetobacter infections - drug therapy (6) 6
anti-bacterial agents - pharmacology (6) 6
association (6) 6
cross infection (6) 6
echocardiography (6) 6
elderly (6) 6
endocarditis - surgery (6) 6
guidelines (6) 6
hepatitis c virus (6) 6
interferon (6) 6
medicine (6) 6
nosocomial infections (6) 6
pseudomonas-aeruginosa (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 3, pp. 349 - 358
Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious infections in critically ill patients. Colistin often remains the only... 
Intensive care units | Health outcomes | Acinetobacter baumannii | Microbial sensitivity tests | Mortality | Acinetobacter | Infections | Hospitalization | ARTICLES AND COMMENTARIES | Dosage | Arm | Treatment efficacy | Ventilator-associated pneumonia | Antimicrobial therapy | Treatment safety | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | ventilator-associated pneumonia | antimicrobial therapy | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | NOSOCOMIAL INFECTIONS | treatment safety | GRAM-NEGATIVE BACTERIA | GLOBAL SPREAD | mortality | MULTIRESISTANT | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | treatment efficacy | NEPHROTOXICITY | Length of Stay | Intensive Care Units | Tertiary Care Centers | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Critical Illness | Male | Treatment Outcome | Acinetobacter Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Drug Resistance, Multiple, Bacterial | Survival Analysis | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Rifampin - therapeutic use | Aged | Acinetobacter baumannii - drug effects | Usage | Colistin | Patient outcomes | Dosage and administration | Drug therapy, Combination | Drug therapy | Rifampin | Health aspects
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 07/2017, Volume 57, Issue 7, pp. 933 - 934
Journal Article
Annals of Hepatology, ISSN 1665-2681, 2015, Volume 14, Issue 1, pp. 75 - 82
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 07/2017, Volume 57, Issue 7, pp. 933 - 934
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 04/2018, Volume 18, Issue 4, pp. 391 - 400
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 11/2014, Volume 40, Issue 11, pp. 1738 - 1741
Journal Article
JAMA, ISSN 0098-7484, 04/2012, Volume 307, Issue 16, pp. 1727 - 1735
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2019
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 02/2018, Volume 20, Issue 1, pp. e12813 - n/a
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 05/2018, Volume 18, Issue 5, pp. 495 - 496
A study showed that both gradient-based and semi-automated devices can overestimate susceptibility to colistin.1 In our trial,2 we recruited patients who were... 
Colistin | Laboratories | Research funding | Mortality | Bacteria | Infections | Meropenem | Gram-negative bacteria | Patients
Journal Article
JAMA, ISSN 0098-7484, 11/2011, Volume 306, Issue 20, pp. 2239 - 2247
Journal Article
CLINICAL MICROBIOLOGY AND INFECTION, ISSN 1198-743X, 08/2019, Volume 25, Issue 8, pp. 943 - 950
Background: Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has... 
INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | Colistin | Mortality | MICROBIOLOGY | Extensively drug-resistant | COMBINATION | Ceftazidime-avibactam | Ertapenem | Fosfomycin | GRAM-NEGATIVE BACTERIA | IMIPENEM-CILASTATIN | DOUBLE-BLIND | Clinical failure | Meropenem | Tigecycline | CRITICALLY-ILL PATIENTS | Klebsiella pneumoniae | KLEBSIELLA-PNEUMONIAE
Journal Article
Clinical Transplantation, ISSN 0902-0063, 06/2019, Volume 33, Issue 6, pp. e13574 - n/a
Hepatitis B core‐related antigen (HBcrAg) has been proposed as a new marker of hepatitis B virus (HBV) replication. We analyzed HBcrAg dynamics in 15 heart... 
heart transplant | hepatitis B core‐related antigen | HBV reactivation | hepatitis B core-related antigen | SURGERY | TRANSPLANTATION | Heart | Antigens | Medical research | Analysis | Medicine, Experimental | Organ transplant recipients | Transplantation | Hepatitis B virus | Health aspects | Hepatitis B
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2009, Volume 49, Issue 4, pp. 498 - 506
Background. Analysis of hepatitis C virus (HCV) RNA kinetics during antiviral therapy may allow estimation of the probability of response. Methods. To assess... 
Health outcomes | RNA | Interferons | Chronic hepatitis | Articles and Commentaries | Fibrosis |